Home
POLA PHARMA

POLA PHARMA Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainpola-pharma.co.jp

Year Founded2007

Employees201 - 500

Annual Revenue$100M - $200M

POLA PHARMA

POLA PHARMA (including company regionals)

pola-pharma.co.jp

See more website traffic and engagement information

POLA PHARMA Revenue up to November 2025 is 100M - 200M

revenue generated by POLA PHARMA top domains

POLA PHARMA top domains revenue over 3 years

Revenue for POLA PHARMA top domains

pola-pharma.co.jp100M - 200M

See more with Sales Intelligence

Total visits to POLA PHARMA's top domains

Understand POLA PHARMA market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in POLA PHARMA's top domains

Analyze POLA PHARMA engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on POLA PHARMA's top domains

See how POLA PHARMA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

POLA PHARMA top competitors by domain

Top similar sites in November 2025, ranked by their affinity

nishika.co.jpCompany NameNippon Shika Yakuhin Co.,Ltd.Employees51 - 200HQJapanAnnual revenue--Total visits11.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by POLA PHARMA

These are the website technologies, by industry, used by POLA PHARMA top domains

Conversion & Analytics (2)

Google Analytics

Mobile (1)

Meta Viewport

Payment & Currencies (1)

Japanese Yen

Social (1)

Ionicons

More Technologies

1

See all

News & Signals from POLA PHARMA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSun Pharma acquired Pola Pharma for $1M on Nov 1st '18.Sun Pharma had entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded, and generic products in Japan, it said in a regulatory filing dated 26 November 2018.

NewsPola Pharma is developing technologies and formulations.Sun Pharma in it's release also added that Pola Pharma has R&D capabilities to develop new technologies and formulations.